Inogen (INGN)
(Delayed Data from NSDQ)
$8.07 USD
-0.45 (-5.28%)
Updated Jun 4, 2024 04:00 PM ET
After-Market: $8.08 +0.01 (0.12%) 7:58 PM ET
2-Buy of 5 2
C Value A Growth B Momentum A VGM
Inogen (INGN) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Downside to Average Price Target |
---|---|---|---|
$7.00 | $7.00 | $7.00 | -17.84% |
Price Target
Based on short-term price targets offered by two analysts, the average price target for Inogen comes to $7.00. The forecasts range from a low of $7.00 to a high of $7.00. The average price target represents a decline of 17.84% from the last closing price of $8.52.
Analyst Price Targets (2 )
Broker Rating
Inogen currently has an average brokerage recommendation (ABR) of 3.00 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by four brokerage firms. The current ABR compares to an ABR of 3.00 a month ago based on four recommendations.
Of the four recommendations deriving the current ABR, one is Strong Buy, representing 25% of all recommendations. A month ago, Strong Buy represented 25%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 1 | 1 | 1 | 1 | 1 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 2 | 2 | 2 | 2 | 2 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 1 | 1 | 1 | 1 | 1 |
ABR | 3.00 | 3.00 | 3.00 | 3.00 | 3.00 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
4/9/2024 | Needham & Company | Michael Matson | Hold | Hold |
2/15/2024 | William Blair | Margaret Kaczor | Hold | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 3.00 |
ABR (Last week) | 3.00 |
# of Recs in ABR | 4 |
Average Target Price | $7.00 |
LT Growth Rate | NA |
Industry | Medical - Instruments |
Industry Rank by ABR | 144 of 252 |
Current Quarter EPS Est: | -0.60 |